Less acidic dye may reduce pancreatitis risk after common procedure
NCT ID NCT07391787
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether using low-acid contrast media (dye) during ERCP can lower the chance of developing pancreatitis afterward. Researchers reviewed records of nearly 4,000 patients from five hospitals. They compared patients who received low-acid contrast media to those who received standard contrast media. The goal is to find a safer option for this common procedure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ioversol, Iohexol (low-acid contrast media)
What this could lead to
If low-acid contrast media works, it could offer a simple way to lower the risk of pancreatitis after ERCP, making the procedure safer.
What could go wrong
This is a retrospective study, not a controlled trial, so results may be influenced by other factors. The benefit may be small or not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-ERCP ACUTE PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, 250012, China
-
Qilu hospital, Shandong University
Jinan, Shandong, China